Published in Hum Mol Genet on June 01, 1999
Nuclear import by karyopherin-βs: recognition and inhibition. Biochim Biophys Acta (2010) 2.19
The POU proteins Brn-2 and Oct-6 share important functions in Schwann cell development. Genes Dev (2003) 2.10
Modular organization and combinatorial energetics of proline-tyrosine nuclear localization signals. PLoS Biol (2008) 1.90
The Gln-Ala repeat transcriptional activator CA150 interacts with huntingtin: neuropathologic and genetic evidence for a role in Huntington's disease pathogenesis. Proc Natl Acad Sci U S A (2001) 1.51
Y65C missense mutation in the WW domain of the Golabi-Ito-Hall syndrome protein PQBP1 affects its binding activity and deregulates pre-mRNA splicing. J Biol Chem (2010) 1.09
Novel truncating mutations in the polyglutamine tract binding protein 1 gene (PQBP1) cause Renpenning syndrome and X-linked mental retardation in another family with microcephaly. Am J Hum Genet (2004) 0.99
Globularity and language-readiness: generating new predictions by expanding the set of genes of interest. Front Psychol (2014) 0.94
PQBP1 Is a Proximal Sensor of the cGAS-Dependent Innate Response to HIV-1. Cell (2015) 0.94
Mutant huntingtin fragment selectively suppresses Brn-2 POU domain transcription factor to mediate hypothalamic cell dysfunction. Hum Mol Genet (2010) 0.90
Suppression of beta-amyloid precursor protein signaling into the nucleus by estrogens mediated through complex formation between the estrogen receptor and Fe65. Mol Cell Biol (2006) 0.89
PQBP1, a factor linked to intellectual disability, affects alternative splicing associated with neurite outgrowth. Genes Dev (2013) 0.89
Proline-rich sequence recognition: I. Marking GYF and WW domain assembly sites in early spliceosomal complexes. Mol Cell Proteomics (2009) 0.87
Solution model of the intrinsically disordered polyglutamine tract-binding protein-1. Biophys J (2012) 0.84
Nematode homologue of PQBP1, a mental retardation causative gene, is involved in lipid metabolism. PLoS One (2009) 0.82
Molecular insights into the WW domain of the Golabi-Ito-Hall syndrome protein PQBP1. FEBS Lett (2012) 0.80
Autoantibody Profiling of Glioma Serum Samples to Identify Biomarkers Using Human Proteome Arrays. Sci Rep (2015) 0.79
FOXP2, retinoic acid, and language: a promising direction. Front Cell Neurosci (2014) 0.78
Sox2 transcriptionally regulates PQBP1, an intellectual disability-microcephaly causative gene, in neural stem progenitor cells. PLoS One (2013) 0.78
In utero gene therapy rescues microcephaly caused by Pqbp1-hypofunction in neural stem progenitor cells. Mol Psychiatry (2014) 0.78
The XLID protein PQBP1 and the GTPase Dynamin 2 define a signaling link that orchestrates ciliary morphogenesis in postmitotic neurons. Cell Rep (2013) 0.78
Structural Insights Reveal the Dynamics of the Repeating r(CAG) Transcript Found in Huntington's Disease (HD) and Spinocerebellar Ataxias (SCAs). PLoS One (2015) 0.77
The splicing factor PQBP1 regulates mesodermal and neural development through FGF signaling. Development (2014) 0.77
WBP-2, a WW domain binding protein, interacts with the thyroid-specific transcription factor Pax8. Biochem J (2004) 0.76
Identification of hepta-histidine as a candidate drug for Huntington's disease by in silico-in vitro- in vivo-integrated screens of chemical libraries. Sci Rep (2016) 0.75
Selection pressure on human STR loci and its relevance in repeat expansion disease. Mol Genet Genomics (2016) 0.75
Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J (1998) 9.36
Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling. Nature (1997) 7.69
Transverse uterine fundal incision for placenta praevia with accreta, involving the entire anterior uterine wall: a case series. BJOG (2013) 7.10
Synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300. Science (1999) 4.69
TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4. EMBO J (1997) 4.48
Smad6 inhibits signalling by the TGF-beta superfamily. Nature (1997) 4.34
A novel octamer binding transcription factor is differentially expressed in mouse embryonic cells. Cell (1990) 3.97
An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy. Nature (1998) 3.86
Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology (1983) 3.67
Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies. Neurology (1993) 3.31
Roles of bone morphogenetic protein type I receptors and Smad proteins in osteoblast and chondroblast differentiation. Mol Biol Cell (1999) 3.27
New surgical method for repair of anomalous left coronary artery from pulmonary artery. J Thorac Cardiovasc Surg (1979) 3.20
Meckel's diverticulum. Investigation of 600 patients in Japanese literature. Am J Surg (1978) 3.04
Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome. Ann Neurol (1992) 3.04
Experimental investigation of geologically produced antineutrinos with KamLAND. Nature (2005) 2.75
Interaction and functional cooperation of PEBP2/CBF with Smads. Synergistic induction of the immunoglobulin germline Calpha promoter. J Biol Chem (1999) 2.44
BMP type II receptor is required for gastrulation and early development of mouse embryos. Dev Biol (2000) 2.40
Structures of sialylated O-linked oligosaccharides of bovine peripheral nerve alpha-dystroglycan. The role of a novel O-mannosyl-type oligosaccharide in the binding of alpha-dystroglycan with laminin. J Biol Chem (1997) 2.38
Benefit of IVIG for long-standing ataxic sensory neuronopathy with Sjögren's syndrome. IV immunoglobulin. Neurology (2003) 2.37
c-Ski acts as a transcriptional co-repressor in transforming growth factor-beta signaling through interaction with smads. J Biol Chem (1999) 2.32
SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein. Hum Mol Genet (2001) 2.30
Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies. Cancer Res (1995) 2.11
HIP1, a human homologue of S. cerevisiae Sla2p, interacts with membrane-associated huntingtin in the brain. Nat Genet (1997) 2.09
Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status. Ann Neurol (1991) 2.08
Low lumbar bone mineral density in patients with major depression. Am J Psychiatry (1994) 2.05
Preferential activation of different I waves by transcranial magnetic stimulation with a figure-of-eight-shaped coil. Exp Brain Res (1997) 2.03
Amantadine as treatment for dyskinesias and motor fluctuations in Parkinson's disease. Neurology (1998) 1.96
Paired-pulse magnetic stimulation of the human motor cortex: differences among I waves. J Physiol (1998) 1.96
Absence of WAF1 mutations in a variety of human malignancies. Blood (1994) 1.95
p27/Kip1 mutation found in breast cancer. Cancer Res (1996) 1.94
Expanded polyglutamine stretches interact with TAFII130, interfering with CREB-dependent transcription. Nat Genet (2000) 1.92
High incidence of ultraviolet-B-or chemical-carcinogen-induced skin tumours in mice lacking the xeroderma pigmentosum group A gene. Nature (1995) 1.91
Kaposi's sarcoma-associated herpesvirus (KSHV or HHV8) in primary effusion lymphoma: ultrastructural demonstration of herpesvirus in lymphoma cells. Blood (1996) 1.89
Smad6 is a Smad1/5-induced smad inhibitor. Characterization of bone morphogenetic protein-responsive element in the mouse Smad6 promoter. J Biol Chem (2000) 1.87
Degradation of alpha-synuclein by proteasome. J Biol Chem (1999) 1.87
Hematoma enlargement in spontaneous intracerebral hemorrhage. J Neurosurg (1994) 1.87
Convergence of transforming growth factor-beta and vitamin D signaling pathways on SMAD transcriptional coactivators. Science (1999) 1.85
Post mortem changes and regional distribution of substance P in the rat and mouse nervous system. Brain Res (1976) 1.82
Left-right asymmetric expression of lefty2 and nodal is induced by a signaling pathway that includes the transcription factor FAST2. Mol Cell (2000) 1.78
Ganglioside composition of the human cranial nerves, with special reference to pathophysiology of Miller Fisher syndrome. Brain Res (1997) 1.76
Effects of hyperglycemia on FDG uptake in human brain and glioma. J Nucl Med (1994) 1.74
Ligand-dependent degradation of Smad3 by a ubiquitin ligase complex of ROC1 and associated proteins. Mol Biol Cell (2001) 1.69
Clear cell carcinoma of the ovary: a retrospective multicentre experience of 254 patients with complete surgical staging. Br J Cancer (2006) 1.67
Successful treatment of refractory bronchorrhea by inhaled indomethacin in two patients with bronchioloalveolar carcinoma. Chest (1999) 1.67
Reduction of GluR2 RNA editing, a molecular change that increases calcium influx through AMPA receptors, selective in the spinal ventral gray of patients with amyotrophic lateral sclerosis. Ann Neurol (1999) 1.67
Nestin expression in the kidney with an obstructed ureter. Kidney Int (2007) 1.66
Transforming growth factor-beta/Smads signaling induces transcription of the cell type-restricted ankyrin repeat protein CARP gene through CAGA motif in vascular smooth muscle cells. Circ Res (2001) 1.66
Characterization of a bone morphogenetic protein-responsive Smad-binding element. Mol Biol Cell (2000) 1.66
A DNA-topoisomerase-II-binding protein with eight repeating regions similar to DNA-repair enzymes and to a cell-cycle regulator. Eur J Biochem (1997) 1.65
The distribution of substance P immunoreactive fibers in the rat central nervous system. J Comp Neurol (1978) 1.63
Melanin production in cultured albino melanocytes transfected with mouse tyrosinase cDNA. Jpn J Genet (1989) 1.61
Characterization of bone morphogenetic protein-6 signaling pathways in osteoblast differentiation. J Cell Sci (1999) 1.61
Magnetic stimulation over the cerebellum in humans. Ann Neurol (1995) 1.61
Multivariate analysis of predictors of hematoma enlargement in spontaneous intracerebral hemorrhage. Stroke (1998) 1.58
Melanization in albino mice transformed by introducing cloned mouse tyrosinase gene. Development (1990) 1.55
Influence of environmental factors on foetal growth in man. Lancet (1967) 1.55
Self-separated hydrothermal lead zirconate titanate thick films for high frequency transducer applications. Appl Phys Lett (2009) 1.52
Endothelin: a novel peptide in the posterior pituitary system. Science (1990) 1.51
Metallic stents for malignant and benign ureteric obstruction. BJU Int (2000) 1.51
Effects of dienogest, a synthetic steroid, on experimental endometriosis in rats. Eur J Endocrinol (1998) 1.51
Anti-GQ1b antibody as a factor predictive of mechanical ventilation in Guillain-Barré syndrome. Neurology (2004) 1.50
DNA aneuploidy in morphologically normal colons from patients with colon cancer. Mod Pathol (1995) 1.48
Adenosine A(2A) receptor antagonist treatment of Parkinson's disease. Neurology (2003) 1.46
Apomorphine responses in Parkinson's disease and the pathogenesis of motor complications. Neurology (1997) 1.46
Usefulness of transcutaneous Doppler jugular venous echo to predict pulmonary hypertension in COPD patients. Eur Respir J (2001) 1.46
HNPCC associated with germline mutation in the TGF-beta type II receptor gene. Nat Genet (1998) 1.45
Diurnal activity and pulsatility of the hypothalamus-pituitary-adrenal system in male depressed patients and healthy controls. J Clin Endocrinol Metab (1997) 1.44
Ultra-early rebleeding in spontaneous subarachnoid hemorrhage. J Neurosurg (1996) 1.44
Overexpression of the c-Myc oncoprotein blocks the growth-inhibitory response but is required for the mitogenic effects of transforming growth factor beta 1. Proc Natl Acad Sci U S A (1995) 1.43
Screening for imprinted genes by allelic message display: identification of a paternally expressed gene impact on mouse chromosome 18. Proc Natl Acad Sci U S A (1997) 1.43
Clival chordoma in early childhood without bone involvement. Childs Nerv Syst (1994) 1.43
Effects of supra-threshold levodopa doses on dyskinesias in advanced Parkinson's disease. Neurology (1997) 1.42
Normal S cone electroretinogram b-wave in Oguchi's disease. Br J Ophthalmol (1997) 1.42
N-acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain-Barré syndrome. Ann Neurol (1994) 1.41
Partial dopamine agonist therapy of levodopa-induced dyskinesias. Neurology (1992) 1.41
Intracortical inhibition of the motor cortex is normal in chorea. J Neurol Neurosurg Psychiatry (1999) 1.41
Microarray analysis of differentially expressed fetal genes in placental tissue derived from early and late onset severe pre-eclampsia. Placenta (2006) 1.39
Anomalously hindered E2 strength B(E2;2+(1)-->0+) in 16C. Phys Rev Lett (2004) 1.39
Real time measurement of heparin concentration during cardiopulmonary bypass. J Cardiovasc Surg (Torino) (1999) 1.39
HTLV-I-associated myelopathy: analysis of 213 patients based on clinical features and laboratory findings. J Neurovirol (1995) 1.39
Loss of mRor1 enhances the heart and skeletal abnormalities in mRor2-deficient mice: redundant and pleiotropic functions of mRor1 and mRor2 receptor tyrosine kinases. Mol Cell Biol (2001) 1.39
Milacemide therapy for Parkinson's disease. Mov Disord (1993) 1.38
Ataxin-3, the MJD1 gene product, interacts with the two human homologs of yeast DNA repair protein RAD23, HHR23A and HHR23B. Hum Mol Genet (2000) 1.38
Vitrectomy for diabetic macular edema: the role of posterior vitreous detachment and epimacular membrane. Am J Ophthalmol (2001) 1.37
Abnormal cerebrovascular network related to the internal cartoid arteries. J Neurosurg (1968) 1.37
Spatio-temporally regulated expression of receptor tyrosine kinases, mRor1, mRor2, during mouse development: implications in development and function of the nervous system. Genes Cells (1999) 1.35
TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia. Blood (1996) 1.33
Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/ tropical spastic paraparesis. J Neurovirol (1996) 1.29
Macular configuration determined by optical coherence tomography after idiopathic macular hole surgery with or without internal limiting membrane peeling. Br J Ophthalmol (2002) 1.29
Immunological identification of an inward rectifier K+ channel (Kir4.1) in the intermediate cell (melanocyte) of the cochlear stria vascularis of gerbils and rats. Cell Tissue Res (1999) 1.28
Substance P: depletion in the dorsal horn of rat spinal cord after section of the peripheral processes of primary sensory neurons. Brain Res (1979) 1.28
Lyme disease in Japan and its possible incriminated tick vector, Ixodes persulcatus. J Infect Dis (1987) 1.28
Inhibition of insulin-induced GLUT4 translocation by Munc18c through interaction with syntaxin4 in 3T3-L1 adipocytes. J Biol Chem (1998) 1.27
Motilin-induced mechanical activity in the canine alimentary tract. Scand J Gastroenterol Suppl (1976) 1.27
Interhemispheric facilitation of the hand motor area in humans. J Physiol (2001) 1.26
[Giant testicular tumor associated with scrotal gangrene: a case report]. Hinyokika Kiyo (1997) 1.26
Radiologic and histopathologic evaluation of canine artery occlusion after collagen-coated platinum microcoil delivery. AJNR Am J Neuroradiol (1999) 1.25
Three-amino acid extension loop homeodomain proteins Meis2 and TGIF differentially regulate transcription. J Biol Chem (2000) 1.25